(0.5mg) Repaglinide , (0.3mg) Voglibose ''''

Repaglinide (0.5mg), Voglibose (0.3mg)
RAPIGLINIDE VOG 0.5  
Repaglinide is a member of the meglitinide class of oral antidiabetic drugs.
Repaglinide stimulates the release of insulin from the pancreas. It does this by binding to the ATP-dependent potassium channels on beta cells in the pancreas, which triggers the release of insulin. This action is similar to the natural response of the body to elevated blood sugar levels after a meal.
Repaglinide is typically used in the treatment of type 2 diabetes, especially in individuals who experience post-meal spikes in blood sugar levels.
Voglibose is an alpha-glucosidase inhibitor, a class of drugs that slow down the digestion of carbohydrates in the intestines.
Voglibose works by inhibiting alpha-glucosidase enzymes in the small intestine. These enzymes are responsible for breaking down complex carbohydrates into simpler sugars. By slowing this process, voglibose helps to delay the absorption of glucose from the digestive tract into the bloodstream, resulting in lower post-meal blood sugar levels.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/rapiglinide-vog-0-5-134238